Overview

Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar

Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of artesuante + amodiaquine four years after its introduction as first line treatment for uncomplicated childhood malaria in Zanzibar. The hypothesis is that the treatment has a polymerase chain reaction (PCR)adjusted parasitological cure rate of at least 85% 42 days after treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska University Hospital
Treatments:
Amodiaquine
Artemisinins
Artesunate